Skip to Main Content

Paper Details

Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction.
Cardiovasc Diabetol
9
2023
Author NameAffiliation
Soko SetoguchiCenter for Pharmacoepidemiology and Treatment Science, Institute for Health, Rutgers University
Soko SetoguchiRutgers Robert Wood Johnson Medical School
  • 1 - 2

Datasets

Release 1.2